XRTX: Rega marang dodolan XORTX Corp

Logo korporat perusahaan XORTX Corp (XRTX)

XORTX Therapeutics Inc. (XRTX) is developing targeted therapies to combat cardiovascular and renal pathologies. The company is mitigating risks by creating therapy to lower uric acid during metabolic disruptions. The current strategic focus is directed toward scaling treatment programs for polycystic kidney disease and identifying biopharma partners. Monitoring the company's P/S ratio visualizes the market valuation of sales, where determines this parameter level.

XRTX (XORTX) riwayat Rasio rega marang pendapatan saka 04.07.2022 nganti 16.11.2026

XORTX (XRTX) - rincian metrik lan laporan keuangan

Ringkesan analitik perusahaan:XORTX (XRTX)
Produk dadi XORTX Therapeutics Inc

The P/S multiple compares the market capitalization of XORTX Therapeutics Inc. (XRTX) with its annual sales volume, determining the cost of each unit of revenue to assess whether the asset is overbought. When analyzing the price-to-sales history, it is critical to consider the biotech ecosystem's lack of a commercial base and its dependence on FDA decisions, which transforms this indicator into a marker of speculative investor expectations regarding future orphan statuses.

Karo sapa XORTX Therapeutics Inc. saingan

argenx - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (biontech.de)|Abivax Corp (ABVX) - Rega marang dodolan|ADMA Corp - Multiplikator P/S|Rasio rega marang dodolan PTGX|Immunovant Inc (IMVT) - Rasio rega marang pendapatan|KNSA - Koefisien rega marang pendapatan|GRFS (Grifols Biemat) - Multiplikator P/S|Multiplikator P/S Adaptive Biotechnologies Inc.|Rasio rega marang pendapatan Celldex Therapeutics (CLDX)|Koefisien rega marang pendapatan auriniapharma.com|Rasio rega marang pendapatan BioCryst Pharmaceuticals BCRX|Rasio kapitalisasi pasar marang pendapatan VERA|Dianthus Pharma - Multiplikator P/S|PHVS - Multiplikator P/S|ABCL: Multiplikator P/S|TRML (Tourmaline Bio, Inc.) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Intrexon|PHAR - Multiplikator rega marang pendapatan|Multiplikator P/S NKTR|Rasio rega marang pendapatan UPB (Upstream Bio Corp)|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|Koefisien rega marang pendapatan immunome.com (IMNM)|Gossamer Bio Inc - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Multiplikator P/S|Kapitalisasi marang pendapatan Pieris Pharmaceuticals Inc|Kapitalisasi marang pendapatan SVRA|Kapitalisasi marang pendapatan Rigel Pharmaceuticals (RIGL)|Multiplikator P/S ANAB|ATXS - Rega marang dodolan|Rasio rega marang pendapatan enGene Corp ENGN|Koefisien rega marang pendapatan RAPT Therapeutics, Inc. (RAPT)|Aerovate - Multiplikator P/S|ACRS - Multiplikator P/S|KYTX (Kyverna Therapeutics) - Kapitalisasi marang pendapatan|Rega marang dodolan Tiziana Life Sciences Ltd. (TLSA)|Kapitalisasi marang pendapatan CABA|Ventyx Biosciences (VTYX) - Koefisien rega marang pendapatan|Multiplikator P/S THTX|AVTX (Avalo Therapeutics, Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELDN (eledon.com)|AGEN - Kapitalisasi marang pendapatan|CLYM - Rasio rega marang pendapatan|Rasio rega marang dodolan ZURA|ATYR: Multiplikator P/S|Adagene Corp (ADAG) - Multiplikator P/S|Kapitalisasi marang pendapatan IMA|Shattuck Labs, Inc. - Rasio rega marang dodolan|Rasio rega marang pendapatan Equillium Inc (EQ)|Multiplikator P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang pendapatan Immunic, Inc. IMUX|Multiplikator P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang pendapatan|XFOR: Rasio rega marang pendapatan|ACET: Multiplikator P/S|CELU - Koefisien rega marang pendapatan|Rasio rega marang pendapatan inmunebio.com|Rasio kapitalisasi marang pendapatan BRNS (barinthusbio.com)|Multiplikator P/S KZR|Multiplikator P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator P/S AKTX (Akari Therapeutics, Plc)|Multiplikator P/S enlivex.com ENLV|QTTB: Kapitalisasi marang pendapatan|GOVX - Multiplikator P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang pendapatan|IBIO - Koefisien rega marang pendapatan|Rasio rega marang pendapatan carismatx.com|XTLB: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan aptevotherapeutics.com APVO|AIM - Kapitalisasi marang pendapatan|Aditxt - Multiplikator P/S|Koefisien rega marang pendapatan GRI Bio Corporation GRI|HIND (Vyome Holdings Inc.) - Kapitalisasi marang pendapatan|revbiosciences.com (REVB) - Multiplikator P/S|INDP (Indaptus Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan Scinai Immunotherapeutics Ltd (SCNI)|Rasio rega marang pendapatan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos Inc.)|Multiplikator P/S HOOKIPA HOOK|IGMS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ITOS (iTeos)|OCEA: Multiplikator P/S|TCBP (TC BioPharm Ltd) - Rasio rega marang pendapatan|THRD (Third Harmonic Bio Inc) - Multiplikator P/S